Financial

Corindus Joins Russell 3000® Index

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that the Company will join the broad-market Russell 3000® Index at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the US market opens on July 1. Annual […]

Quantum Genomics Announces Result of Annual General Meeting

PARIS and NEW YORK, June 27, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart failure, informs its shareholders that […]

Medtronic Announces the Upsizing of its Maximum Tender Offer to up to $4.35 billion for Certain Outstanding Debt Securities Issued by Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A.

DUBLIN, June 25, 2019 (GLOBE NEWSWIRE) — Medtronic plc (the “Company”) (NYSE:MDT) today announced the upsizing of the previously announced cash tender offer (the “Maximum Tender Offer”) by its wholly-owned indirect subsidiaries, Medtronic, Inc., Medtronic Global Holdings S.C.A. (“MGH”) and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc. […]

Boston Scientific Presents Strategies for Sustained Long-Range Growth Targets at 2019 Investor Day

MARLBOROUGH, Mass., June 26, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is hosting a meeting with the investment community today in New York City to review its business and long-term growth strategies. The company is presenting plans for its product pipeline and strategic investments to enable improved clinical and economic outcomes, sustain category leadership […]

Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

VANCOUVER, June 25, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ:NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has received written notification (the “Nasdaq […]

East Bay Cardiovascular and Thoracic Associates Partners with Health Prime to Get Revenue Cycle Management Back on Track

NATIONAL HARBOR, Md.–(BUSINESS WIRE)–Health Prime, a leading provider of revenue cycle management services, today announced that East Bay Cardiovascular and Thoracic Associates, a premier multi-specialty surgical group, has signed a partnership agreement for revenue cycle management services. Health Prime was brought onboard to scale operations and optimize current revenue opportunities. […]

Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales

LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Daniel Prewitt as the senior vice president of sales. In this role, Prewitt will be responsible for leading the Company’s sales to health plans and self-funded employers. Bringing over […]

Samuel E. Navarro Appointed to BioSig Board of Directors

Santa Monica, CA, June 25, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed to address an unmet need for the electrophysiology (EP) marketplace, today appointed Samuel E. Navarro to its Board of Directors. Mr. Navarro brings to BioSig […]

InterVene Raises $15 Million in Series B Funding for First Catheter-Based System to Correct Deep Vein Valve Failure

SOUTH SAN FRANCISCO–(BUSINESS WIRE)–InterVene Inc. today announced it has raised $15 million in a Series B financing round. The company’s BlueLeaf® Endovenous Valve Formation System is the first catheter-based solution for deep vein reflux (DVR) — the failure of venous valves in the legs — that does not require an implant. […]